Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $5,624.0M | $6,283.0M | $7,821.0M | $8,357.0M | $8,050.0M | $8,188.0M | $7,806.0M | $7,622.0M | $7,249.0M | $7,143.0M | $7,380.0M | $7,477.0M | $8,386.0M | $9,048.0M | $9,823.0M | $10.7B | $9,913.0M | $11.9B | $12.7B | $14.2B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Boston Scientific Corporation's last 12-month Revenue is $15.9B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Boston Scientific Corporation's Revenue growth was 15.7%. The average annual Revenue growth rates for Boston Scientific Corporation have been 16.3% over the past three years, 8.9% over the past five years.
Over the last year, Boston Scientific Corporation's Revenue growth was 15.7%, which is higher than industry growth of 0.1%. It indicates that Boston Scientific Corporation's Revenue growth is Good.